Amgen Canada is proud to share an online video series they have developed on biosimilars. The videos were released today in the digital version of The Globe & Mail.
For the past several months, Amgen has worked with The Globe & Mail to create these online videos that cover the key issues on biosimilars. Participants included Amgen Canada’s Karen Burke, who provided perspective on biosimilars in general; Jackie Manthorne, CEO from the Canadian Cancer Survivor Network, who provided the patient perspective; and Michael Reilly, Executive Director from the Alliance for Safe Biologic Medicines, who provided a global perspective on biosimilars, with a focus on why manufacturing matters.
We hope you will enjoy the video!
Find out more here: http://www.theglobeandmail.